Abstract
The p53 tumor suppressor protein and the Akt/PKB kinase play important roles in the transduction of pro-apoptotic and anti-apoptotic signals, respectively. We provide evidence that conflicting signals transduced by Akt and p53 are integrated via negative feedback between the two pathways. On the one hand, the combination of ionizing radiation and survival factor deprivation, which leads to rapid apoptosis of IL-3 dependent DA-1 cells, entails a caspase- and p53-dependent destruction of Akt. This destruction of Akt is not a secondary consequence of apoptosis, since it is not seen when the same cells are triggered to undergo apoptosis under different conditions. On the other hand upon serum stimulation, when Akt becomes active and enhances cell survival, phosphorylation occurs at an Akt consensus site (serine 166) within the Mdm2 protein, a key regulator of p53 function. Taken together, our findings suggest that depending on the balance of signals, p53-dependent downregulation of Akt may promote an irreversible commitment to apoptotic cell death, whereas effective recruitment of Akt by appropriate survival signals may lead to activation of Mdm2, inactivation of p53, and eventually inhibition of p53-dependent apoptosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bachelder RE, Ribick MJ, Marchetti A, Falcioni R, Soddu S, Davis KR, Mercurio AM . 1999 J. Cell. Biol. 147: 1063–1072
Bachelder RE, Wendt MA, Fujita N, Tsuruo T, Mercurio AM . 2001 J. Biol. Chem. 276: 34702–34707
Chen J, Marechal V, Levine AJ . 1993 Mol. Cell. Biol. 13: 4107–4114
Chen J, Wu X, Lin J, Levine AJ . 1996 Mol. Cell. Biol. 16: 2445–2452
Datta SR, Brunet A, Greenberg ME . 1999 Genes Dev. 13: 2905–2927
Ding HF, McGill G, Rowan S, Schmaltz C, Shimamura A, Fisher DE . 1998 J. Biol. Chem. 273: 28378–28383
Freedman DA, Wu L, Levine AJ . 1999 Cell Mol. Life Sci. 55: 96–107
Gottlieb E, Haffner R, von Ruden T, Wagner EF, Oren M . 1994 EMBO J. 13: 1368–1374
Gottlieb E, Lindner S, Oren M . 1996 Cell Growth Diff. 7: 301–310
Gottlieb E, Oren M . 1998 EMBO J. 17: 3587–3596
Gottlieb TM, Oren M . 1996 Biochim. Biophys. Acta. 1267: 77–102
Haupt Y, Barak Y, Oren M . 1996 EMBO J. 15: 1596–1606
Juven-Gershon T, Oren M . 1999 Mol. Med. 5: 71–83
Khanna KK, Jackson SP . 2001 Nat. Genet. 27: 247–254
Kohn AD, Takeuchi F, Roth RA . 1996 J. Biol. Chem. 271: 21920–21926
Mathieu AL, Gonin S, Leverrier Y, Blanquier B, Thomas J, Dantin C, Martin G, Baverel G, Marvel J . 2001 J. Biol. Chem. 276: 10935–10942
Mayo LD, Donner DB . 2001 Proc. Natl. Acad. Sci. USA 98: 11598–11603
Miyashita T, Reed JC . 1995 Cell 80: 293–299
Moll UM, Zaika A . 2001 FEBS Lett. 493: 65–69
Momand J, Wu HH, Dasgupta G . 2000 Gene 242: 15–29
Obata T, Yaffe MB, Leparc GG, Piro ET, Maegawa H, Kashiwagi A, Kikkawa R, Cantley LC . 2000 J. Biol. Chem. 275: 36108–36115
Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T, Nishimori H, Tamai K, Tokino T, Nakamura Y, Taya Y . 2000 Cell 102: 849–862
Oren M . 1999 J. Biol. Chem. 274: 36031–36034
Pochampally R, Fodera B, Chen L, Lu W, Chen J . 1999 J. Biol. Chem. 274: 15271–15277
Rich T, Allen RL, Wyllie AH . 2000 Nature, 407: 777–783
Rokudai S, Fujita N, Hashimoto Y, Tsuruo T . 2000 J. Cell Physiol. 182: 290–296
Sabbatini P, McCormick F . 1999 J. Biol. Chem. 274: 24263–24269
Scheid MP, Woodgett JR . 2000 Curr. Biol. 10: R191–R194
Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P, Green DR . 2000 J. Biol. Chem. 275: 7337–7342
Shaulian E, Zauberman A, Ginsberg D, Oren M . 1992 Mol. Cell. Biol. 12: 5581–5592
Vousden KH . 2000 Cell 103: 691–694
Widmann C, Gibson S, Johnson GL . 1998 J. Biol. Chem. 273: 7141–7147
Yamaguchi A, Tamatani M, Matsuzaki H, Namikawa K, Kiyama H, Vitek MP, Mitsuda N, Tohyama M . 2000 J. Biol. Chem. 27: 27–
Acknowledgements
We thank D Freedman and AJ Levine for Mdm2-specific monoclonal antibodies and RA Roth for Akt expression plasmids. This work was supported in part by grant RO1 CA 40099 from the National Cancer Institute (USA), The USA-Israel Binational Science Foundation, the Kadoorie Charitable Foundations, the Cooperation Program in Cancer Research of the DKFZ and Israel's Ministry of Science (MOS), the Robert Bosch Foundation (Germany) and the Yad Abraham Center for Cancer Diagnosis and Therapy. T Gottlieb was the recipient of an ICRF fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gottlieb, T., Leal, J., Seger, R. et al. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. Oncogene 21, 1299–1303 (2002). https://doi.org/10.1038/sj.onc.1205181
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205181
Keywords
This article is cited by
-
Protective effect of hygrolansamycin C against corticosterone-induced toxicity and oxidative stress-mediated via autophagy and the MAPK signaling pathway
Pharmacological Reports (2024)
-
Loss of the centrosomal protein ALMS1 alters lipid metabolism and the regulation of extracellular matrix-related processes
Biology Direct (2023)
-
Emerging role and therapeutic implications of p53 in intervertebral disc degeneration
Cell Death Discovery (2023)
-
WD repeat domain 82 (Wdr82) facilitates mouse iPSCs generation by interfering mitochondrial oxidative phosphorylation and glycolysis
Cellular and Molecular Life Sciences (2023)
-
CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis
Oncogene (2022)